APA (7th ed.) Citation

N, T., AM, M., & KC, W. (2018). Idarucizumab for Reversing Dabigatran-Induced Anticoagulation: A Systematic Review. American journal of therapeutics, 25(3), e333. https://doi.org/10.1097/MJT.0000000000000460

Chicago Style (17th ed.) Citation

N, Thibault, Morrill AM, and Willett KC. "Idarucizumab for Reversing Dabigatran-Induced Anticoagulation: A Systematic Review." American Journal of Therapeutics 25, no. 3 (2018): e333. https://doi.org/10.1097/MJT.0000000000000460.

MLA (9th ed.) Citation

N, Thibault, et al. "Idarucizumab for Reversing Dabigatran-Induced Anticoagulation: A Systematic Review." American Journal of Therapeutics, vol. 25, no. 3, 2018, p. e333, https://doi.org/10.1097/MJT.0000000000000460.